- 57
-
Prostate Cancer Screening: Weigh Risks, Benefits With ...
American Cancer Society — The debate over prostate cancer screening still rages on, despite the release of early results from 2 large randomized clinical trials investigating the issue in the New England Journal of Medicine today. Since screening became fairly common in ...More…
-
Background on Prostate Cancer
National Cancer Institute — The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, or PLCO, is a large-scale clinical trial to determine whether certain cancer screening tests reduce the number of deaths from these cancers. Screening for cancer may enable ...More…
-
Prostate Cancer Prevention: The Scoop on Supplements
American Cancer Society — In 2001, researchers from the National Cancer Institute (NCI) and the Southwest Oncology Group (SWOG) launched the massive SELECT study (short for Selenium and Vitamin E Cancer Prevention Trial) to find out whether taking selenium and vitamin E ...More…
-
FDA Approves New Drug for Advanced Prostate Cancer
American Cancer Society — Degarelix, an injectable drug manufactured by Ferring Pharmaceuticals and still awaiting a trade name before it can hit the market, belongs to class of drugs known as gonadotropin-releasing hormone (GnRH) receptor antagonists. These drugs block ...More…
-
Additional Prostate Cancer Information and Resources:
Radiology Info — Prostate cancer is the most common form of cancer in American men, most prevalent in men over age 65 and fairly common in men 50-64 years old. However, prostate cancer can occur in men younger than 50. The incidence of diagnosed prostate cancer ...More…
-
Prostate cancer guide
Mayo Clinic — Prostate cancer treatment options - Consider the different factors before making your decision. Being diagnosed with prostate cancer can be scary. It can lead you to fear, panic and hurried decisions. You may feel that you need to make a quick ...More…
-
Review of Prostate Cancer Prevention Study Shows No ...
National Institutes of Health — SELECT participants are receiving letters explaining the study review and telling them to stop taking their study supplements. Participants will continue to have their health monitored by study staff, which may include regular digital rectal ...More…
-
Review of Prostate Cancer Prevention Study Shows No ...
National Institutes of Health — Data and additional analyses of the SELECT trial were published online December 9, 2008, in JAMA. Among the specific results highlighted, the five-year rate of prostate cancer diagnosis in the four arms of the study was 4.43 percent in the ...More…
-
FDA Approves Drug for Patients with Advanced Prostate Cancer
Food & Drug Administration — FDA Approves Drug for Patients with Advanced Prostate Cancer The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer. Degarelix is intended to treat patients ...More…
-
Studies Make Case for Finasteride to Prevent Prostate Cancer
National Cancer Institute — Adapted from the NCI Cancer Bulletin, vol. 5/no. 11, May 27, 2008 (see the current issue). The initial results from the largest completed prostate cancer prevention trial appear to have underestimated the benefits and overestimated the potential ...More…
-
Prostate Cancer Patients Pick Treatments That May Worsen ...
American Cancer Society — Men with early-stage prostate cancer frequently choose treatments that worsen problems they already have, according to a new study published in Cancer. Researchers from Boston University School of Public Health, Dana-Farber Cancer Institute, ...More…
-
Your Prostate Cancer Risk
Washington University St Louis — Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of MedicineMore…